Clinical Trials in Pennsylvania

Showing 3021-3040 of 9,383 trials

reSET-O RCT (Randomized Controlled Trial)

NCT04129580

This randomized controlled trial research study will be evaluating an app, reSET-O, owned by Pear Therapeutics, Inc., to evaluate treatment retention rates in individuals with opioid use disorder after initiating medication assisted treatment.

Opioid-use Disorder

Milton S. Hershey Medical Center100 participantsStarted Sep 2020

Harrisburg, Pennsylvania, United States

COMPLETEDPhase 236 miles

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

NCT01064622

This randomized phase I/II trial studies gemcitabine hydrochloride and vismodegib to see how well they work compared with gemcitabine hydrochloride alone in treating patients with recurrent or metastatic pancreatic cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Vismodegib may slow the growth of tumor cells. It is not yet known whether giving gemcitabine hydrochloride together with vismodegib is more effective than gemcitabine hydrochloride alone in treating patients with pancreatic cancer.

Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7

National Cancer Institute (NCI)118 participantsStarted Sep 2009

Beverly Hills, California, United States • Duarte, California, United States • Los Angeles, California, United States +22 more locations

reSET-O RCT (Randomized Controlled Trial)

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Find Trials by Condition in Pennsylvania

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Pediatric Adenotonsillectomy Trial for Snoring

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC